Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...

A week after one New Haven-based biotechnology company announced a mass layoff, another has announced plans to cut 40% of its workforce. RallyBio, based at 234 Church St., in New Haven ...

Another biotechnology company has set its sights on the Triangle with major plans to develop obesity drugs. San Francisco-based Genentech plans to create up to 420 high-paying jobs in Holly ...

One of them is definitely sector-specific tariffs. The 50% estimation is a manageable impact for many of the biotech companies, but there are also other challenges being floated. Another factor is ...

Regeneron Pharmaceuticals is purchasing genetics and biotechnology company 23andMe and has vowed to protect customer data while continuing genome testing services. Regeneron announced the purchase ...

May 9 (UPI) --A South Korean biotech company is likely to benefit greatly from the policy of the U.S. Food and Drug Administration, which is scheduled to retire animal testing. Organoid Science ...

is a biotech company dedicated to clean, innovative solutions, and will bring a new facility to the Spartanburg Community College’s Spark Center, in Duncan. The facility will focus on plant ...

SAN FRANCISCO (KRON) — Elizabeth Holmes is still locked up in prison for defrauding investors who believed in her biotech startup company, Theranos. The disgraced entrepreneur pitched her ...

LONDON, May 14 (Reuters) - Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry grows that layoffs and policy changes at the ...